Home » Newsletters » BioWorld

BioWorld

Feb. 3, 1993

View Archived Issues

SMOKING OUT P53'S ROLE IN TOBACCO-RELATED CANCER

GLYKO LURES CANADIAN AND EUROPEAN INVESTORS

THERATECH FILES FOR FDA APPROVAL

U.S. BIOSCIENCE FILES NDA FOR AIDS DRUG

TRIPLEX AWARDED TWO TECHNOLOGY PATENTS

HEAD TRAUMA DRUG FOR INTERNEURON

CYTEL COMPLETES $21 MILLION SECONDARY OFFERING

CALGENE GROSSES $29.5 MILLION IN OFFERING

BIO-RAD PATENT RULED INVALID

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...